Naviguer dans les réglementations pharmaceutiques mondiales : Normes USP, EP et ISO en 2026

Titre : Navigating the Regulatory Landscape: A 2026 Guide to Global Pharmaceutical Standards

Sous-titre : How Zhengzhou PharGlass ensures compliance with USP, EP, JP, and ISO regulations to secure your global supply chain.

Date : 13 avril 2026
Auteur : Zhengzhou PharGlass Regulatory Affairs Team

In the pharmaceutical industry, compliance is not optional—it is the license to operate. As we progress through 2026, the regulatory environment has become more complex. The focus has shifted from simple material testing to holistic system performance, emphasizing Extractables & Leachables (E&L), container closure integrity, and quality management systems.

For manufacturers and exporters, understanding these nuances is critical. At Zhengzhou PharGlass, we stay ahead of these curves to ensure your products face no barriers at customs or in clinical trials.

Here is your essential update on the regulatory standards defining our industry in 2026.

---

1. The USP Evolution: From Material to System

The United States Pharmacopeia (USP) remains the gold standard for the North American market. In 2026, the focus is heavily on USP <661> series and USP <1207>.

🧪 USP <661.1> & <661.2>: The Plastic Shift

While glass remains inert, the regulations for plastic components (caps, seals) have tightened.

• The Update: The industry has moved beyond simple physicochemical testing. The new standards require a rigorous assessment of Extractables and Leachables (E&L). This means we must prove that no harmful organic or inorganic substances migrate from the packaging into the drug.
• Zhengzhou PharGlass Compliance: For our Oral Liquid Bottles and capped vials, we utilize materials that meet these stringent biological safety evaluations, ensuring compatibility with sensitive formulations.

🔍 USP <1207>: Container Closure Integrity (CCIT)

Sterility is paramount. USP <1207> mandates deterministic testing methods (like Vacuum Decay or High Voltage Leak Detection) rather than probabilistic methods (like Dye Ingress).

• Our Standard: Notre Glass Tubing is engineered with precise dimensional tolerances (vertical axis deviation <1.2mm) to ensure a perfect seal with rubber stoppers, passing the strictest CCIT protocols.

2. ISO 15378: The Quality Management Benchmark

While ISO 9001 is general, ISO 15378 is specific to primary packaging materials. It integrates Good Manufacturing Practice (GMP) requirements directly into the packaging manufacturing process.

🏭 Why It Matters

In 2026, pharmaceutical companies are under immense pressure to audit their supply chains. They cannot afford suppliers with “change management” issues.

• Change Control: ISO 15378 requires that any change in raw materials or process (e.g., changing a glass furnace supplier) must be validated and communicated.
• Zhengzhou PharGlass Commitment: We adhere to strict change control protocols. Our 30 years of experience ensures that our processes are stable, documented, and audit-ready, reducing the regulatory burden on our clients.

3. The Asian Markets: JP and NMPA Updates

For companies exporting to Japan and China, the landscape is equally dynamic.

🇯🇵 Japanese Pharmacopoeia (JP)

The current JP18 (18th Edition) places significant emphasis on elemental impurities (ICH Q3D) and the physical stability of glass.

• Hydrolytic Resistance: JP standards strictly test for glass delamination. Our Verre borosilicaté moyen is formulated to meet the high hydrolytic resistance required by the Japanese market, preventing “flaking” in high-pH solutions.

🇨🇳 China NMPA & YBB Standards

The National Medical Products Administration (NMPA) continues to align its YBB (Yaobao Baozhuang) standards with international norms.

• Recent Updates: New guidelines on “Drug-Container Interaction” require comprehensive compatibility studies.
• Our Readiness: As a domestic leader, Zhengzhou PharGlass provides full technical dossiers supporting YBB registration, covering everything from internal stress (<400nm/mm) to heavy metal limits.

4. Material Specifics: Glass vs. Polymer Regulations

Different materials face different regulatory hurdles.

🥃 Glass (DIN / ISO / USP Type I)

• Standard: DIN ISO 9187-1 for ampoules and ISO 8362-1 for vials.
• Focus: Chemical durability (Acid/Base resistance). Our glass meets USP Type I et EP Type I requirements, making it suitable for blood and plasma derivatives.

🧴 Polymers (Polyethylene/Polypropylene)

• Standard: Recent updates in 2026 (such as the Basic Requirements for Polyethylene used in Pharmaceutical Packaging Materials) demand strict control over additives.
• Focus: Manufacturers must declare all additives to ensure they do not exceed safety thresholds. We ensure our polymer components are compliant with GB 4806 (Food Contact) and pharmaceutical specific migration limits.

---

Conclusion: Compliance is a Partnership

Navigating the alphabet soup of USP, EP, JP, and ISO can be daunting. However, at Zhengzhou PharGlass, compliance is built into our DNA. From the chemical formulation of our glass to the cleanliness of our packaging, we ensure that every component we ship is ready for global regulatory scrutiny.

Need a Compliance Partner?
Contact Zhengzhou PharGlass today to request our latest Regulatory Master Files and Certificates of Analysis.